基因沉默
肺纤维化
博莱霉素
纤维化
癌症研究
功能(生物学)
细胞生物学
肺
RNA干扰
肺功能
医学
病理
生物
内科学
化疗
基因
核糖核酸
遗传学
作者
T Yuan,A Nicholas,N Lakomski,Maria Afrazi,Haylee L. Hamilton,Julia Hegge,JACOB HAMILTON,T Pei,E.W. Bush
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2022-09-04
卷期号:: 864-864
被引量:10
标识
DOI:10.1183/13993003.congress-2022.864
摘要
Introduction: In idiopathic pulmonary fibrosis (IPF), aberrant basaloid cells overexpress matrix metalloproteinase 7 (MMP7), a validated biomarker of disease severity. MMP7 activity promotes fibrosis and inflammation but development of traditional selective small molecule inhibitors has been challenging. We utilized Arrowhead’s pulmonary epithelium-targeted RNAi delivery platform to silence lung MMP7 expression in a rat IPF model. Methods: Integrin targeting ligand-conjugated siRNAs specific for silencing MMP7 mRNA were intratracheally delivered to rats prior to bleomycin administration followed by serial evaluation of indices of fibrosis and pulmonary function. Lead MMP7 siRNA conjugates were also evaluated in primates and in ex vivo human lung slices. Results: Bleomycin injury provoked lung MMP7 overexpression, primarily in KRT17+ aberrant basaloid cells. MMP7 siRNA conjugate treatment silenced MMP7 expression by 60-90% and significantly improved Ashcroft histology scores, limited pro-fibrotic gene expression and collagen deposition, and reduced inflammation (lavage eosinophil and neutrophil counts). Reduced fibrosis was accompanied by increased lung compliance and oxygen saturation, reductions in weight loss and improved survival. An inhaled dose of a lead candidate silenced 80-90% of lung MMP7 mRNA and protein expression in primates and was similarly active in cultured human lung slices. Conclusions: Integrin targeting ligand-conjugated siRNAs potently silence MMP7 expression, limit fibrosis and improve lung function in the rat bleomycin model. ARO-MMP7 is a promising new therapeutic candidate for the treatment of IPF.
科研通智能强力驱动
Strongly Powered by AbleSci AI